Matches 1 - 50 out of 197 1 2 3 4 >

AcclaimIP-ad

Match Document Document Title
US20110020450 TITRATABLE DOSAGE TRANSDERMAL DELIVERY SYSTEM  
The present invention relates to a titratable dosage transdermal delivery system for systemic delivery of a therapeutic agent or drug. The system comprises a plurality of patch units that are...
US20100316749 TOPICAL DELIVERY OF L-ARGININE TO CAUSE BENEFICIAL EFFECTS  
The application of L-arginine and its derivatives to the skin causes beneficial effects of wound healing, increasing erectile function and increased growth of hair when applied in sufficient...
US20080188556 Water-Soluble Prodrugs of Florfenicol and its Analogs  
The present invention discloses certain novel prodrugs of florfenicol and/or of florfenicol analogs, including prodrugs of salts pharmaceutically acceptable salts of florfenicol and its analogs,...
US20110237563 FAST DISSOLVING DRUG DELIVERY SYSTEMS  
The present invention related to the administration of bioactive agents via oral fast dispersing/dissolving drug delivery systems for treating illnesses of patient with critical buccal condition,...
US20100331819 Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy  
This invention relates to photodynamic therapy (PDT), more specifically PDT for atherosclerotic plaque via delivering PDT-loaded nanoparticles such as liposomes, polymersomes, micelles and...
US20150218256 COMPOUNDS FOR TREATING THE REMYELINATION BLOCKADE IN DISEASES ASSOCIATED WITH THE EXPRESSION OF HERV-W ENVELOPE PROTEIN  
The present invention deals with innovative compounds and compositions for preventing and/or treating a newly discovered detrimental mechanism, which blocks the endogenous myelin repair capacity...
US20150133408 COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESTLESS LEG SYNDROME AND FIBROMYALGIA  
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical...
US20100092420 Preservative Systems Comprising Cationic Surfactants  
Preservative systems on the basis of cationic surfactants are known i n the art, a typical example of such cationic surfactants is the ethyl ester of the lauramide of arginine monohydrochloride...
US20140057787 COATING COMPOSITIONS FOR PATHOGEN CONTROL IN SOYBEAN  
Coating composition for soya bean seed from which roots and shoots are capable of growing, wherein the coating composition comprises an organic carrier material and one or more biological agents...
US20110112188 Treatment of Inflammatory Conditions  
The invention relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin thereby treating or prevention various diseases, disorders or...
US20100310543 METHOD OF PREVENTING AND TREATING ACUTE BRAIN PATHOLOGIES  
Described are novel means in the treatment of cerebral neurological conditions such as ischemic insult of the brain. Furthermore, a kit for a non-radioactive protein serine/threonine phosphatase...
US20130289059 BENEFICIAL EFFECTS OF INCREASING LOCAL BLOOD FLOW  
The present invention generally relates to the improvement of tissue health by increasing local blood flow. In some aspects of the invention, increased local blood flow is effected by the...
US20110028548 BENEFICIAL EFFECTS OF INCREASING LOCAL BLOOD FLOW  
The present invention generally relates to the improvement of tissue health by increasing local blood flow. In some aspects of the invention, increased local blood flow is effected by the...
US20150209377 Use of Novel Monosaccharide-like Glycylated Sugar Alcohol Compositions for Designing and Developing Anti-Diabetic Drugs  
This invention is related to a novel sugar-like chemical composition and its use for diabetes therapy. Particularly, the present invention teaches the use of monosaccharide-like glycylated sugar...
US20120328544 Dermatological Treatment Methods And Formulations  
A dermatological composition for application to the skin or nails comprises a salt of a cation and an anion. The cation is derived from a monomeric or polymeric molecule that will generate an...
US20120237567 MODULATING LYMPHATIC FUNCTION  
Methods and compositions for modulating lymphatic function, e.g., by altering NO levels, are disclosed.
US20130345171 TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE AND THROMBOSIS  
Provided herein are compositions for the treatment and/or prevention of cardiovascular disease (CVD), and methods of application and use thereof. In particular, the present invention provides...
US20100034795 USE OF L-CARNITINE OR ALKANYL L-CARNITINE FOR THE PREPARATION OF A DIETARY SUPPLEMENT OR MEDICAMENT FOR THE TREATMENT OF CORNEAL DISEASE  
Use of L-carnitine and/or one or more alkanoyl L-carnitines or one of their pharmaceutically acceptable salts for the preparation of a dietary supplement or medicament for the treatment of corneal...
US20130039956 USE OF NITROCARBOXYLIC ACIDS FOR THE TREATMENT, DIAGNOSIS AND PROPHYLAXIS OF AGGRESSIVE HEALING PATTERNS  
The invention is directed to implants and medical devices having at least one layer which contains at least one nitrocarboxylic acid. These implants and medical devices shall be used for the...
US20150094314 METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE  
A method of modulating ribonucleotide reductase activity in a neoplastic cell includes administering to the cell an amount of a ribonucleotide reductase allosteric modulator (RRAmod), the amount...
US20150203446 DI-ALIPHATIC SUBSTITUTED PEGYLATED LIPIDS  
The disclosure relates to di-aliphatic substituted PEGylated lipids and to methods of their preparation. The disclosure also relates to lipid conjugates containing di-aliphatic substituted...
US20120087968 Antimicrobial Packaging Material and Methods of Making and Using the Same  
The presently disclosed subject matter is generally directed to packaging materials comprising at least one antimicrobial agent. Particularly, the disclosed packaging materials incorporate, via...
US20090326031 ANTIVIRAL USE OF CATIONIC SURFACTANT  
Cationic surfactants derived from the condensation of fatty acids and esterified dibasic amino acids, such as from lauric acid and arginine, in particular the ethyl ester of the lauramide of the...
US20110003887 TREATING ONCOGENIC RAS DRIVEN CANCERS  
Oncogenic Ras-driven cancer is treated with agent by interrupting pathway comprising activation of Akt by oncogenic Ras, activated Akt causing phosphorylation of eNOS at S1177 site of eNOS to...
US20110135711 Methods and Compositions for Delivery of Catecholic Butanes for Treatment of Tumors  
The present invention provides kits, methods and compositions for the treatment of diseases such as cancers. The compositions herein contain a substantially pure preparation of at least one...
US20140010761 FORM OF HEXYL-5-AMINOLEVULINATE HYDROCHLORIDE AND METHODS OF USING THE SAME  
This invention relates to a novel crystalline polymorph of hexyl-5-aminolevulinate hydrochloride, referred to hereinafter as Form C, which is useful as precursor of a photo sensitizer in the...
US20110230558 USE OF CATIONIC SURFACTANTS FOR THE INACTIVATION OF TOXINS  
This invention relates to a use of a composition for the inactivation of toxins containing cationic surfactants such as ethyl-Nα-lauroyl-L-arginate HCI (LAE). It has been found that cationic...
US20130035381 VIRUS-INACTIVATING COMPOSITION CONTAINING LOW-MOLECULAR WEIGHT COMPOUND AND ARGININE  
The invention provides a virus-inactivating composition with pH of 3.8 to 5.5, containing (A) 0.02 to 0.3 M arginine and (B) a component such as 0.01 to 10 mM flavonoid, polyphenol, or ascorbic...
US20130136704 P-MENTHANE-3,8-DIOL ISOMER MIXTURE, COMPOSITION COMPRISING THE SAME, AND PRODUCTS COMPRISING THE MIXTURE OR COMPOSITION  
An object of the present invention is to provide a novel technology for preventing crystal precipitation of p-menthane-3,8-diol, and stable products utilizing this technology. Provided is a...
US20110111066 METHOD AND COMPOSITION FOR IMPROVED ANABOLISM  
Nutritional compositions are provided containing at least one PPAR agonist, at least one PGC-1alpha agonist, and at least one creatine derivative. Methods of promoting anabolism and improving or...
US20140031403 Solid Forms of Curcumin  
The present invention provides forms of curcumin and the pharmaceutical compositions thereof. The forms of curcumin disclosed herein are curcumin polymorph Form III, curcumin-2-aminobenzimidazole...
US20110034476 GENETIC POLYMORPHISMS AND INFERTILITY  
Methods of screening for a cause of low sperm motility and/or for mitochondrial impairment in subjects are provided, comprising determining a genotype of the subject with respect to at least one...
US20110091576 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells  
A method for the treatment and prophylaxis of conditions of aging due oxidative stress and as growth factors of stem cells. Such conditions due to oxidative stress are associated with a decreased...
US20120015998 PHOTOTHERAPY METHODS AND DEVICES COMPRISING EMISSIVE ARYL-HETEROARYL COMPOUNDS  
Disclosed herein are compounds represented by a formula: R1—Ar1—X—Ar2—Ar3-Het, wherein R1, Ar1, X, Ar2, Ar3, and Het are described herein. Compositions and light-emitting devices related thereto...
US20100144691 Treatment of Female Fertility Conditions Through Modulation of the Autonomic Nervous System  
Methods are provided for treating a subject for a fertility condition. In accordance with the subject methods, at least a portion of a subject's autonomic nervous system is modulated to increase...
US20090325963 Iontophoretic Delivery of Curcumin and Curcumin Analogs for the Treatment of Alzheimer's Disease  
A method of delivering a curcuminoid to a patient, which includes iontophoretically delivering a charged curcuminoid across the skin of an Alzheimer's Disease patient.
US20110020228 TARGETED CELLULAR SELECTIVITY OF SURFACE ACTIVE MOLECULES  
A method for the treatment of cancer involves delivering a surface active agent to an organism, where the surface active agent selectively partitions to and kills cancer cells as opposed to...
US20080242726 Trans-Clomiphene for the Treatment of Benign Prostate Hypertrophy, Porstate Cancer, Hypogonadism Elevated Triglycerides and High Cholesterol  
Compositions comprising trans-clomiphene may be used in treating benign prostate hypertrophy, prostate cancer, elevated triglyceride levels and hypogonadism.
US20140288142 NITRIC OXIDE DONOR COMPOUNDS  
The invention relates to nitric oxide donor compounds and their use for treating cardiovascular diseases, inflammation, pain, fever, gastrointestinal disorders, ophthalmic diseases, hepatic...
US20140121270 FORMULATIONS AND METHODS TO PROVIDE NUTRITION TO HUMAN AND OTHER PATIENTS  
Systems, techniques and methods for estimating the metabolic state or flux, e.g., the body energy state (“BES”) of a patient, are disclosed. The BES provides deep insight into the nutritional...
US20140121269 FORMULATIONS AND METHODS TO PROVIDE NUTRITION TO HUMAN AND OTHER PATIENTS  
Systems, techniques and methods for estimating the metabolic state or flux, e.g., the body energy state (“BES”) of a patient, are disclosed. The BES provides deep insight into the nutritional...
US20110054023 Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses  
The presently disclosed subject matter generally relates to methods and compositions for inhibiting the expression and/or activation of hypoxia-inducible factor 1 (HIF-1) genes in a cancer cell,...
US20080268077 Process for Strengthening the Barrier Function of Undamaged Skin  
A process is described for strengthening the barrier function of undamaged skin in particular against allergens and/or for preventing or inhibiting an allergic reaction of undamaged skin on...
US20090202464 Fragrance Compounds  
A method of providing a fragrant odour to an application, comprising the addition thereto of at least one compound of the formula (I) wherein X and Y are independently selected from the group...
US20140309302 Antimicrobial Preservative Compositions for Personal Care Products  
A personal product antimicrobial preservative composition for preservation of topical personal care formulations is provided and includes [A] one or more undecylenic acid derivatives depicted by...
US20100028325 New Combination Of Cationic Preservatives With Taste-Masking Components  
Use of cationic surfactants, derived from the condensation of fatty acids and esterified dibasic amino acids, of the formula (1): occasionally leads to a bitter taste, when the compound is present...
US20080305135 Wasp repellents  
A method of repelling wasps, which method comprises using a preparation comprising (a) one or more of ethyl 3-(N-n-butyl-N-acetylamino)propionate, dihydronepetalactone, and extract of catmint, and...
US20150079163 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE  
The present disclosure provides antimicrobial compounds, compositions comprising such antimicrobial compounds, and methods of their use, in particular, antibacterial compounds and antifungal...
US20140357713 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE  
The present disclosure provides antimicrobial compounds, compositions comprising such antimicrobial compounds, and methods of their use, in particular, antibacterial compounds and antifungal...
US20140170207 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE  
The present disclosure provides antimicrobial compounds, compositions comprising such antimicrobial compounds, and methods of their use, in particular, antibacterial compounds and antifungal...
Matches 1 - 50 out of 197 1 2 3 4 >